CA Patent

CA2800094C — Liquid nasal spray containing low-dose naltrexone

Assigned to L Molteni and C dei Fratelli Alitti Societa di Esercizio SpA · Expires 2018-05-29 · 8y expired

What this patent protects

Liquid formulations for administration of naltrexone at low concentrations by the nasal route are described.

USPTO Abstract

Liquid formulations for administration of naltrexone at low concentrations by the nasal route are described.

Drugs covered by this patent

Patent Metadata

Patent number
CA2800094C
Jurisdiction
CA
Classification
—
Expires
2018-05-29
Drug substance claim
No
Drug product claim
No
Assignee
L Molteni and C dei Fratelli Alitti Societa di Esercizio SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.